tiprankstipranks
Trending News
More News >
Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607)
:2607

Shanghai Pharmaceuticals Holding Co (2607) Revenue

Compare
4 Followers

Shanghai Pharmaceuticals Holding Co Revenue

Shanghai Pharmaceuticals Holding Co had a revenue of 70.76B in the quarter ending Mar 31, 2025, with 7.83%. This bring the company's revenue in the last twelve months to 275.86B, Decreased 0.22%. In the fiscal year ending Dec 31, 2024, Shanghai Pharmaceuticals Holding Co had annual revenue of 275.25B with 5.75% growth.
Revenue (ttm)
275.86B
Revenue Growth
3.27%
P/S Ratio
0.23
Revenue/Employee
$5,571,656
Employees
49,402
Market Cap
$64.33B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
275.25B14.96B+5.75%
Dec 31, 2023
260.30B28.31B+12.21%
Dec 31, 2022
231.98B16.16B+7.49%
Dec 31, 2021
215.82B23.92B+12.46%
Dec 31, 2020
191.91B5.34B+2.86%
Dec 31, 2019
186.57B27.48B+17.27%
Dec 31, 2018
159.08B28.24B+21.58%
Dec 31, 2017
130.85B10.08B+8.35%
Dec 31, 2016
120.76B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis